249 related articles for article (PubMed ID: 18067412)
1. Identification of accessible human cancer biomarkers using ex vivo chemical proteomic strategies.
Kischel P; Waltregny D; Castronovo V
Expert Rev Proteomics; 2007 Dec; 4(6):727-39. PubMed ID: 18067412
[TBL] [Abstract][Full Text] [Related]
2. [Targeted therapy: toward a clean and effective war against cancer].
Castronovo V; Waltregny D; Detry O; Coimbra Marques C; De Roover A; Honoré P; De Pauw E; Turtoi A
Rev Med Liege; 2009; 64 Spec No():20-3. PubMed ID: 20085011
[TBL] [Abstract][Full Text] [Related]
3. Identification of specific reachable molecular targets in human breast cancer using a versatile ex vivo proteomic method.
Castronovo V; Kischel P; Guillonneau F; de Leval L; Deféchereux T; De Pauw E; Neri D; Waltregny D
Proteomics; 2007 Apr; 7(8):1188-96. PubMed ID: 17372937
[TBL] [Abstract][Full Text] [Related]
4. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
[TBL] [Abstract][Full Text] [Related]
5. Novel comprehensive approach for accessible biomarker identification and absolute quantification from precious human tissues.
Turtoi A; Dumont B; Greffe Y; Blomme A; Mazzucchelli G; Delvenne P; Mutijima EN; Lifrange E; De Pauw E; Castronovo V
J Proteome Res; 2011 Jul; 10(7):3160-82. PubMed ID: 21534635
[TBL] [Abstract][Full Text] [Related]
6. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.
Sun S; Lee NP; Poon RT; Fan ST; He QY; Lau GK; Luk JM
Liver Int; 2007 Oct; 27(8):1021-38. PubMed ID: 17845530
[TBL] [Abstract][Full Text] [Related]
7. An introduction into proteomics and its clinical applications.
Ahram M
Saudi Med J; 2007 Apr; 28(4):499-507. PubMed ID: 17457467
[TBL] [Abstract][Full Text] [Related]
8. Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry.
Engwegen JY; Gast MC; Schellens JH; Beijnen JH
Trends Pharmacol Sci; 2006 May; 27(5):251-9. PubMed ID: 16600386
[TBL] [Abstract][Full Text] [Related]
9. Advanced proteomic technologies for cancer biomarker discovery.
Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
[TBL] [Abstract][Full Text] [Related]
10. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
[TBL] [Abstract][Full Text] [Related]
11. Strategies for revealing lower abundance proteins in two-dimensional protein maps.
Ahmed N; Rice GE
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):39-50. PubMed ID: 15652797
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.
Roblick UJ; Bader FG; Hammarstedt L; Habermann JK; Hellman U; Becker S; Sundmacker A; Gemoll T; Zimmermann K; Auer G; Munck-Wikland E
Acta Oncol; 2008; 47(8):1493-501. PubMed ID: 18759147
[TBL] [Abstract][Full Text] [Related]
13. In vivo protein biotinylation and sample preparation for the proteomic identification of organ- and disease-specific antigens accessible from the vasculature.
Roesli C; Neri D; Rybak JN
Nat Protoc; 2006; 1(1):192-9. PubMed ID: 17406232
[TBL] [Abstract][Full Text] [Related]
14. Clinical cancer proteomics: promises and pitfalls.
Alaiya A; Al-Mohanna M; Linder S
J Proteome Res; 2005; 4(4):1213-22. PubMed ID: 16083271
[TBL] [Abstract][Full Text] [Related]
15. Expanding the protein catalogue in the proteome reference map of human breast cancer cells.
Pucci-Minafra I; Cancemi P; Fontana S; Minafra L; Feo S; Becchi M; Freyria AM; Minafra S
Proteomics; 2006 Apr; 6(8):2609-25. PubMed ID: 16526084
[TBL] [Abstract][Full Text] [Related]
16. Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine.
Honda K; Ono M; Shitashige M; Masuda M; Kamita M; Miura N; Yamada T
Jpn J Clin Oncol; 2013 Feb; 43(2):103-9. PubMed ID: 23248327
[TBL] [Abstract][Full Text] [Related]
17. [Application of proteomics to diagnosis and treatment of lung cancer].
Dai M; Luo RC
Ai Zheng; 2007 Jun; 26(6):669-72. PubMed ID: 17562279
[TBL] [Abstract][Full Text] [Related]
18. Biomarker discovery: a proteomic approach for brain cancer profiling.
Khalil AA
Cancer Sci; 2007 Feb; 98(2):201-13. PubMed ID: 17233837
[TBL] [Abstract][Full Text] [Related]
19. Present status of clinical proteomic analysis for the early detection and determination of therapeutic strategy in lung cancer.
Hirano T; Kato H
Ann Thorac Cardiovasc Surg; 2006 Feb; 12(1):4-9. PubMed ID: 16572067
[TBL] [Abstract][Full Text] [Related]
20. Cancer proteomics: Serum diagnostics for tumor marker discovery.
Rai AJ; Chan DW
Ann N Y Acad Sci; 2004 Jun; 1022():286-94. PubMed ID: 15251974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
